Powered by Made-in-China.com

Tamsulosin Hydrochloride Sustained Release Capsules 0.4mg, USP

Beijing, ChinaBeijing DC-Pharma Co., Ltd.

Tamsulosin Hydrochloride Sustained Release Capsules 0.4mg, USP

US$0.01-0.10

100,000 Tablet

Product profile

Application

Internal Medicine

Usage Mode

For oral administration

Suitable for

Elderly, Adult

Model NO.

0.4mg

State

Solid

Shape

Capsules

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

Guoyaozhunzi

Standard

USP

Certificate

GMP

Market

Foreign

Packaging

Blister with Box

Transport Package

Blister with Box in Carton

Specification

0.4mg

Trademark

Manufacturer

Origin

P. R. China

HS Code

3004909099

Production Capacity

10 Million Boxes/Year

Company profile

Beijing DC-Pharma Co., Ltd.

Years of Export ExperienceHigh Repeat Buyers ChoiceImporters and ExportersMulti-language Pioneer

Beijing DC-Pharma Co., Ltd.

Beijing, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2022-03-25Average Response Time: ≤24hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB

About Our Factory & Business Background

AddressRoom No. 217, Second Floor, Wangjing Street, Chaoyang Dist, Beijing, china

Average Lead TimePeak Season Lead Time: 1-3 months Off Season Lead Time: 1-3 months

Our Production Capability & Technical Expertise

Main ProductsInjections, Ampoules, Tablets, Capsules, Powder

Our Industry Experience & Global Business Record

Main MarketsEastern Europe, Southeast Asia, Mid East

Send Inquiry

*To:

Beijing DC-Pharma Co., Ltd.

Beijing DC-Pharma Co., Ltd.

*Content:

0/4000

Supplier replies will be sent to your registered email